About OSL

Formed in 1999, Oncology Systems Limited, has continuously grown to become a major independent provider of medical equipment and software to the NHS and private hospitals in the U.K. and Ireland. OSL's wholly owned state of the art radiotherapy clinical and medical physics QA software is distributed globally through its international distributor partners.

OSL’s products enable clinicians to deliver the highest quality therapies for the treatment of cancer. These include: intensity modulated radiotherapy (IMRT), image guided radiotherapy (IGRT), adaptive radiotherapy (ART), stereotactic radiosurgery (SRS), stereotactic ablative radiotherapy (SABR), stereotactic body radiotherapy (SBRT) and urology.

OSL provides a wide range of clinical and technical radiation therapy equipment from thermoplastic to 4D simulation and imaging, in the areas of immobilisation, treatment planning and medical physics QA. The Company and its customers benefit from all its applications and sales staff being clinically and scientifically qualified radiation therapists or medical physicists/clinical scientists.

In 2003, OSL achieved the international quality accreditation to ISO 9001:2001, which was upgraded to ISO 9000:2008. From 2013 onward OSL incorporated the requirements of ISO 13485:2003, EN ISO 13485:2012 and attained Directive 93/42/EEC on medical devices, Annex II (excluding Section 4) for its own manufactured software; OnQ rts.


anatom-e logo 200px

cemar logo 200px

cortex logo 200px

IBA_Logo_ Base_Pos_CMYK_highres 200px

Logo MACROMEDICS.100 200px

math resolution logo 200px

logo 200px

modus qa logo 200px

Zeiss_Logo for web 200px

This page was printed from OSL Web site at http://www.osl.uk.com